Zobrazeno 1 - 10
of 121
pro vyhledávání: '"T.-T. Pelliniemi"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Jouppila, Juhani Vilpo, E. Järvenpää, M. Kááriáinen, C. Wasastjerna, Heikki Hallman, Allan Rajamäki, A. Hänninen, G. Järventie, D. Nyman, Erkki Elonen, J. Savola, I. P. Palva, S. Pakkala, Tapani Ruutu, K. Soininen, B. Isomaa, T-T. Pelliniemi, P. Nyländen, E. Koivunen, T. Oivanen, H. Mäkelä, K. Kätkä, Reino Lahtinen, T. Pulli, M. Lehtinen, A. Laitinen, A. Almqvist, Tuomo Timonen, H. Kilpi, K. Ala Harja, P. Ahrenberg, M. Ilvonen
Publikováno v:
European Journal of Haematology. 44:121-124
94 patients with refractory multiple myeloma were treated in a multicentre trial with combinations of cytotoxic drugs including anthracyclines. All were refractory to a 5-drug combination containing 3 alkylating agents, vincristine and methylpredniso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6c38882c057c4fbd001103386004e76
https://doi.org/10.1111/j.1600-0609.1990.tb00362.x
https://doi.org/10.1111/j.1600-0609.1990.tb00362.x
Autor:
A. Tienhaara, T.-T. Pelliniemi
Publikováno v:
Clinical & Laboratory Haematology. 16:213-223
Peripheral blood lymphocyte subsets were analysed by flow cytometry and compared among 43 patients with untreated multiple myeloma (MM), 16 patients with monoclonal gammopathy of undetermined significance (MGUS) and 26 controls. The age and sex distr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::847975180822f6f42c9ec9603c88d42e
https://doi.org/10.1111/j.1365-2257.1994.tb00414.x
https://doi.org/10.1111/j.1365-2257.1994.tb00414.x
Publikováno v:
Cytotherapy. 9:548-554
Successful stem cell mobilization is a prerequisite for autologous blood cell transplantation. We analyzed factors that may predict the success of stem cell mobilization in patients with multiple myeloma (MM).We analyzed 124 consecutive patients and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad7fcafc7323d5909274cc2652303112
https://doi.org/10.1080/14653240701508429
https://doi.org/10.1080/14653240701508429
Publikováno v:
Journal of Hematotherapy & Stem Cell Research. 12:63-70
Positive CD34(+) selection to purge blood cell harvests is one way to attempt to reduce the high relapse risk after high-dose chemotherapy (HDT) supported by autologous blood cell transplantation (ABCT) in patients with multiple myeloma (MM). Until r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eefc4a21f01076e6f92f97424ee7348
https://doi.org/10.1089/152581603321210145
https://doi.org/10.1089/152581603321210145
Autor:
Kari Koskela, Kari Pulkki, T-T Pelliniemi, Lauri J. Pelliniemi, Kari Punnonen, K-O Södeström, Hanna Ollikainen, Rajesh Kumar, Kari Remes
Publikováno v:
Acta Haematologica. 107:23-28
Human myeloma cell lines are difficult to establish, and they usually originate from patients with extramedullary disease. We describe a new human myeloma cell line, TU-1, which was established from the bone marrow of a patient without extramedullary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::157a1955c9e5b6004d0450e4018c2f0f
https://doi.org/10.1159/000046625
https://doi.org/10.1159/000046625
Autor:
T-L Penttila, Tuomas Selander, Tuija Lundán, V. Huotari, Pekka Anttila, Veli Kairisto, Kari Remes, Mervi Putkonen, Lasse Uotila, T-T Pelliniemi, Vesa Juvonen, Pentti Mäntymaa, Sanna Siitonen, Raija Silvennoinen
Publikováno v:
Blood Cancer Journal
Multiparameter flow cytometry (MFC) and allele-specific oligonucleotide real-time quantitative PCR (ASO RQ-PCR) are the two most sensitive methods to detect minimal residual disease (MRD) in multiple myeloma (MM). We compared these methods in 129 pai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1dadf7641f3099870f3dfcd5d9a6824
https://doi.org/10.1038/bcj.2014.69
https://doi.org/10.1038/bcj.2014.69
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cancer. 92(4)
Interferon-alpha has proven effective in the treatment of metastatic renal cell carcinoma. However, the optimal schedule has not yet been determined. The authors have studied the efficacy and toxicity of prolonged use interferon-alpha2a (IFN-alpha) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bb2892fda6e47eb8d950fa220918741c
https://pubmed.ncbi.nlm.nih.gov/11550145
https://pubmed.ncbi.nlm.nih.gov/11550145
Autor:
T T, Pelliniemi
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 114(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5ac4d6003cd4a92dc354a0799a20c7e2
https://pubmed.ncbi.nlm.nih.gov/11524763
https://pubmed.ncbi.nlm.nih.gov/11524763